BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sanaria Inc. 

12115 Parklawn Drive
Suite L
Rockville  Maryland  20852  U.S.A.
Phone: 301-770-3222 Fax: 301-770-5554


SEARCH JOBS




Industry
Diagnostics

Segment
Vaccines





 Company News
Sanaria Inc.'s Malaria Vaccine Impresses in Phase 1 Trial 8/9/2013 5:54:29 AM    More...
Malaria Vaccine Developer Sanaria Inc.. and the Institute for Bioscience and Biotechnology Research of the University of Maryland College Park Awarded Collaborative, US $3M National Institutes of Health (NIH) Phase II Small Business Innovation Research Grant 6/14/2012 10:21:35 AM    More...
Malaria Parasite and Mosquito Products and Assay Services Available for Sale by Sanaria Inc. 6/30/2011 5:58:55 AM    More...
Sanaria Inc. Receives Multi-Year U.S. NIH Phase II Small Business Innovation Research Grant to Develop a Genetically Attenuated Whole Parasite Malaria Vaccine 2/23/2010 11:32:06 AM    More...
Sanaria Inc. Release: Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 4/23/2009 8:27:34 AM    More...
Malaria Vaccine Plant Sanaria Inc. Takes a Gamble 10/29/2007 10:06:23 AM    More...
Biotech Company Sanaria Inc. To Open New Malaria Vaccine Plant 10/25/2007 12:30:48 AM    More...
Sanaria Inc. Receives Multi-Year $3.47 Million U.S. FDA Phase I And Phase II Small Business Innovation Research Grants To Enhance Development Of Its Malaria Vaccine 1/29/2007 12:37:40 PM    More...